Get started
Cannabis Strategic VenturesCannabis Strategic VenturesCannabis Strategic Ventures

Cannabis Strategic Ventures

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

NUGS trade ideas

WEED STOCK THOUGHTS! HEXO, ACB, APHAHey everyone! Here with a video on some Cannabis Stocks I've been checking out. (THIS VIDEO, HEXO, APHA, ACB) Day time frame: Most of the cannabis stocks are looking very similar. -completed Market Cycle -Down 80-100% -lower MA's have crossed north, or are close to crossing 200MA in Bullish form IMO these are looking like great places to invest if you wish to do so. I am no financial advisor, just a trader sharing my thoughts and ideas! PLEASE LIKE COMMENT AND FOLLOW! AND REMEMBER, DON'T CHASE IT, RETRACE IT!
OTC:NUGSLong
by Cosmicbag
Cannabis Strategic Ventures - $NUGS Weekly ChartNuG$ acts as a holding company developing a portfolio of profitable subsidiaries operating in the legalized cannabis industry. They only operate in those states where cannabis is legalized and regulated under applicable state laws, and/or has been de-criminalized for medical use and/or legalized for recreational use. Currently, their subsidiary holdings are considered non-operational. $NUGS subsidiaries include: ● Pure Applied Sciences, Inc., a Delaware corporation engaged in the marketing and sales of its “PureOrganics™” brand of cannabis oils and related accessories; ● Fitamins, Inc., a Wyoming corporation, engaged in the marketing and sale of a brand of health and wellness products containing hemp-based CBD; and, ● Lyxr™, a brand of based luxury skin, hair and body products containing hemp-based CBD and other Phyto cannabinoids and other natural ingredients providing high-performing skin, hair and body topical solutions; and, ● BudHire, a staffing solution brand operating in Washington and California that provides temporary, long term and permanent staffing solutions for the Cannabis industry; and, ● NUGS Farm North owns 16 cannabis cultivation licenses, one nursery license, one distribution license, and one processing license in Northern California. ● FLORAH, a CBD only retail store conceptualized for launch in Los Angeles. Resources cannabisstrategic.com cannabisstrategic.com www.sec.gov Important Notes below www.sec.gov Results of Operations For the three months ended June 30, 2020 compared to fiscal year ended June 30, 2019. Revenues and Cost of Revenues Total revenues were $3,372,537 for the three months ended June 30, 2020 as compared to $161,158 for the three months ended June 30, 2019, an increase of $3,211,379. The increase in revenues was due to our sales from sale of Cannabis products and income from BudHire staffing services. Cost of revenues were $2,477,285 or 73.45% of total revenues for the three months ended June 30, 2020, versus $184,234 or 114.32% of total revenues for the three months ended June 30, 2019. This increase in costs of sales was due to our BudHire operations, whereby we invoice our staffing clients, who pay us a fee, and we account for the costs of paying placed employees for the staffing services provided and the cost to grow and harvest the cannabis in NUGS Farm North. Gross Profit Total gross profit was $895,252 for the three months ended June 30, 2020. This compares to total gross loss of $(23,076) for the three months ended June 30, 2019. Total gross profits for the three months ended June 30, 2020 as compared to 2019 reflect an increase of $918,328. Operating Expenses Total operating expenses were $2,312,505, for the three months ended June 30, 2020, as compared to $2,104,115 for the three months ended June 30, 2019. This increase was primarily due to more leases expense in the NUGS Farm North for the three months ended June 30, 2020. Other Income (Expense) Other income (expense) for the three months ended June 30, 2020 was income of $19,906 as compared with expense of ($187,544) for the three months ended June 30, 2019. This decrease in expense was due to reduction in loss in investing activity. Net Income (Loss) As a result of the factors discussed above, loss for the three months ended June 30, 2020 was ($1,420,032) as compared to a loss for the three months ended June 30, 2019 of ($2,308,156). Lower net-loss from 2019 which is a good sign Results of Operations For the fiscal year ended March 31, 2020 compared to fiscal year ended March 31, 2019. Revenues and Cost of Revenues Total revenues were $2,367,367 for the year ended March 31, 2020 as compared to $701,968 for the year ended March 31, 2019, an increase of $1,665,399. The increase in revenues was due to our sales from sale of Cannabis products and income from BudHire staffing services. Cost of revenues were $1,890,496 or 79.86% of total revenues for the year ended March 31, 2020, versus $680,917 or 97% of total revenues for the year ended March 31, 2019. This increase in costs of sales was due to our BudHire operations, whereby we invoice our staffing clients, who pay us a fee, and we account for the costs of paying placed employees for the staffing services provided and the cost to grow and harvest the cannabis in NUGS Farm North. Solid growth in Revenues atleast they are proving they can make the $$$ Gross Profit Total gross profit was $476,871 for the year ended March 31, 2020. This compares to total gross profit of $21,051 for the year ended March 31, 2019. Total gross profits for the year ended year ended March 31, 2020 as compared to 2019 reflect an increase of $455,820. Operating Expenses Total operating expenses were $9,053,806, for the year ended March 31, 2020, as compared to $21,136,801 for the year ended March 31, 2019. This decrease was primarily due to decrease in stock compensation expense of $1,471,277 for the year ended March 31, 2020 compare to $19,341,321 for the year ended March 31, 2019. Also, the Company incurred more leases expense in the NUGS Farm North for the year ended March 31, 2020. Other Income (Expense) Other income (expense) for the year ended March 31, 2020 was expense of ($461,456) as compared with expense of ($319,615) for the year ended March 31, 2019. This increase in expense was due to a loss in investing activity. Net Income (Loss) As a result of the factors discussed above, loss for the year ended March 31, 2020 was ($9,079,609) as compared to a loss for the year ended March 31, 2019 of ($21,432,605). This is a HUGE plus, the fact they lowered their net-loss from 21mil down to 10mil is a great sign lookingforward. Liquidity and Capital Resources As of June 30, 2020, our primary internal sources of liquidity were our working capital, which included cash and cash equivalents of $456,630, accounts receivable of $947,898, inventory of $2,955,039, and other receivables of $82.646. We have, during the period ended June 30, 2020, relied upon external financing arrangements to fund our operations. During the period ended June 30, 2020, we entered into several separate financing arrangements, to fund our Northern California cannabis grow and cultivation operation. Our ability to rely upon external financing arrangements to fund operations is not certain, and this may limit our ability to secure future funding from external sources without changes in terms requested by counterparties, changes in the valuation of collateral, and associated risk, each of which is reasonably likely to result in our liquidity decreasing in a material way. We intend to utilize cash on hand, loans and other forms of financing such as the sale of additional equity and debt securities and other credit facilities to conduct our ongoing business, and to also conduct strategic business development and implementation of our business plans generally. Our ability to timely complete our payment commitments is contingent upon our having to raise additional capital, which is not certain. Our ability to access additional funding through external financing arrangements is uncertain, and could possibly include terms and conditions pertaining to the valuation of collateral and associated risk, each of which is reasonably likely to result in our liquidity decreasing in a material way. For the three months ended June 30, 2020 compared to fiscal year ended June 30, 2019. Operating Activities Net cash used by operating activities for the three months ended June 30, 2020 was a use of ($1,348,691) and ($429,287) for the three months ended June 30, 2019. Investing Activities For the three months ended June 30, 2020 and 2019, investing activities were a use of cash of ($6,478) and ($2,735,147) respectively. Financing Activities For the three months ended June 30, 2020 and 2019, the net cash from financing activities was $1,323,335 and $3,304,601 respectively. For the fiscal year ended March 31, 2020 compared to fiscal year ended March 31, 2019. Operating Activities Net cash used by operating activities for the year ended March 31, 2020 was a use of ($7,642,740) and ($2,531,612) for the year ended March 31, 2019. Investing Activities For the years ended March 31, 2020 and 2019, investing activities were a use of cash of ($3,402,893) and ($144,200) respectively. Financing Activities For the years ended March 31, 2020 and 2019, the net cash from financing activities was $11,459,428 and $2,346,976 respectively. Off Balance Sheet Arrangements As of June 30, 2020 and March 31, 2020, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. Shares Reclass During the year ended March 31, 2020, the Company issued 7,277,856 shares to employees and non-employees for their stock compensation accrued as of March 31, 2019. Going Concern The Company sustained continued operating losses during the three months ended June 30, 2020 and 2019. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations, in which it has not been successful, and/or obtaining additional financing from its shareholders or other sources, as may be required. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the accompanying financial statements, the Company had an accumulated deficit of approximately $46.9 million at June 30, 2020, and net loss of $1.4 million for the three months ended June 30, 2020. These factors among others raise substantial doubt about the Company’s ability to continue as a going concern. All in All if your still reading, I see potential for $NUGS to spike higher on the weekly. Still take profits when you see those narly gains! Acucumulation zone: .002500-->.10 Looking for a decent swing higher in the coming months. GLTA & may the NUGZ BE WITH US$
OTC:NUGSLong
by AaronX
NUGS Rounded Base Pressing Toward Breakout on Big Growth DataOTC:NUGS has been on the move in recent weeks. The pattern is now a near-perfect rounded base, implying a near-term target at $0.20.. meaning a double from here if the pattern plays out and we trigger a breakout through trendline resistance. Cannabis Strategic Ventures (OTCMKTS:NUGS) just put out word that it will have an expanded inventory ready for sales and shipment next week after a sharp surge in sales in early May left the Company “sold out” every week for the past month for the first time in its history. This is a name that recently expanded its total production capacity by as much as 150% (ie, more than doubled its cannabis production) likely because of its growing distribution partnerships, which represent the main driver for sales for a company like this. The California cannabis marketplace is seeing a shortage right now, so producers have the best context possible – unless they aren’t in a position to expand production. NUGS, luckily for its shareholders, has been able to scale up to capitalize on the context and drive what looks to be a pretty dramatic topline growth acceleration. To wit: Cannabis Strategic Ventures (OTCMKTS:NUGS) is coming off a record month of sales in April, where it booked orders at an annualized pace exceeding $10 million. In all, April sales came in more than 800% higher than the average monthly sales performance logged during the Company’s calendar Q1 – momentum that has carried over into May sales data. “We have never seen anything like this,” noted Simon Yu, CEO of Cannabis Strategic Ventures. “We booked $100,000 in one day to clear out all of our remaining inventory. We anticipated this dynamic but still underestimated the force of the trend. Too much demand is always the problem you want to have. And we are confident we will be able to translate this into further upside in terms of our top line growth curve.”
OTC:NUGSLong
by GregFolin